期刊文献+

研究盐酸法舒地尔用于脑心综合征治疗中的临床效果 被引量:1

The Clinical Effect of Fasudil Hydrochloride for the Treatment of Cerebral Cardiac Syndrome
下载PDF
导出
摘要 目的研究盐酸法舒地尔用于脑心综合征治疗中的临床效果。方法 2014年5月~2015年5月选择100例在我院治疗的脑心综合征患者,在遵照患者个人意愿的前提下采用随机方法,将其分为观察组(50例)与对照组(50例),对照组采用常规方法治疗,观察组在对照组基础上加用盐酸法舒地尔治疗,比较两组的临床疗效。结果治疗后对比两组患者的总有效率,观察组患者(94.00%)高于对照组患者(70.00%),对比两组的不良反应发生情况,观察组(0.00%)优于对照组(6.00%),两组比较差异具有统计学意义(P〈0.05)。结论对脑心综合征患者采用盐酸法舒地尔治疗,临床效果较好。 Objective Study of fasudil hydrochloride for cerebral heart syndrome in the clinical effect of comprehensive treatment. Methods 100 patients with cerebral heart syndrome treated in our hospital were selected from May 2014 to May 2015, on the premise of comply with patients individual aspiration with random method, it can be divided into observation group(50 cases) and control group(50 cases) and control group using conventional method, the observation group in the control group with hydrochloric acid on the basis of nursing method of fasudil hydrochloride, methods of treatment, two groups of clinical curative effect. Results The total effective rate compared two groups of patients after treatment, patients(94.00%) of the observation group was obviously higher than that of control group(70.00%) patients, compared two groups of adverse reactions occur, observation group(0.00%) than the control group(6.00%), comparing the two groups have statistical significance(P〈0.05). Conclusion Comprehensive treatment with fasudil hydrochloride on brain heart syndrome patients, the clinical effect is better.
作者 许玫
出处 《中国继续医学教育》 2015年第32期124-125,共2页 China Continuing Medical Education
关键词 盐酸法舒地尔 脑心综合征 临床疗效 Fasudil hydrochloride Brain heart syndrome Clinical curative effect
  • 相关文献

参考文献3

二级参考文献21

  • 1Treggiari MM,Walder B,Suter PM,et al.Systematic review of theprevention of delayed ischemic neurological deficits with hyperten-sion,hypervolemia,and hemodilution therapy following subarach-noid hemorrhage[J].J Neurosurg,2003,98(5):978-984.
  • 2Amano M,Fukata Y,Kaibuchi K.Regulation and functions of rhoas-sociated kinase[J].Exp Cell Res,2000,261(1):44-51.
  • 3Shibuya M,Asano T,Sasaki Y.Effect of fasudil HCI,a protein ki-nase inhibitor,on cerebral vasospasm[J].Acta Neurochir Suppl,2001,77:201-204.
  • 4Rikitake Y,Kim HH,Huang Z,et al.Inhibition of Rho kinase(ROCK)leads to increased cerebral blood flow and stroke protec-tion[J].Stroke,2005,36(10):2251-2257.
  • 5Wettschureck N,Offermanns S.Rhokinase mediated singnaling inphysiology and pathophysiology[J].J Mol Med,2002,80(10):629-638.
  • 6Kitagawa YE. Daravone in acute ischemic stroke. Int Med(TokyoJapan), 2006,45(5):225-226.
  • 7Oppenheimer S. Cerebrogenic cardiac arrhythmias: crticallateralization and clinical significance. Clin Auton Res, 2006, 16(1):6-11.
  • 8Nakamura T, Kuroda Y, Yamashita S, et al. Edaravone attenuatesbrainedema and neurologic deficits in a rat model of acuteintracerebral hemorrhage. Stroke, 2008, 39(2):463-469.
  • 9谢虎.急性脑卒中与脑心综合征分析[J].西南军医,2008,10(3):29-30. 被引量:10
  • 10林香玉,黄萍,栾秀香,王丽华,于天林,曲瑞云,黄河亮.Rho激酶抑制剂对急性缺血性脑卒中的治疗研究[J].中国现代药物应用,2008,2(13):23-24. 被引量:5

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部